![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 4
Zeitschriftenartikel
Müller, Volkmar; Hein, Alexander; Hartkopf, Andreas D.; Fasching, Peter A.; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haberle, Lothar; Ettl, Johannes; Luftner, Diana; Wallwiener, Markus; Beckmann, Matthias W.; Schneeweiss, Andreas; Belleville, Erik; Uhrig, Sabrina; Wimberger, Pauline; Hielscher, Carsten; Meyer, Julia; Wurmthaler, Lena A.; Kurbacher, Christian M.; Wuerstlein, Rachel; Untch, Michael; Janni, Wolfgang; Taran, Florin-Andrei; Lux, Michael P.; Wallwiener, Diethelm; Brucker, Sara Y.; Fehm, Tanja N. und Michel, Laura L.
(2022):
Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics- A retrospective analysis of a real world registry.
In: European Journal of Cancer, Bd. 172: S. 13-21
Schneeweiss, Andreas; Ettl, Johannes; Lueftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Haberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhaberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christian; Kurbacher, Christian M.; Klein, Evelyn; Lux, Michael P.; Müller, Volkmar; Nabieva, Naiba; Overkamp, Friedrich; Tesch, Hans; Laakmann, Elena; Taran, Florin-Andrei; Seitz, Julia; Thomssen, Christoph; Untch, Michael; Wimberger, Pauline; Würstlein, Rachel; Volz, Bernhard; Wallwiener, Diethelm; Wallwiener, Markus und Brucker, Sara Y.
(2020):
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.
In: Breast, Bd. 54: S. 88-95
de Gregorio, Amelie; Haberle, Lothar; Fasching, Peter A.; Müller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; de Gregorio, Nikolaus; Deniz, Miriam; Fink, Visnja; Bekes, Inga; Andergassen, Ulrich; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Lato, Krisztian; Beckmann, Matthias W.; Rack, Brigitte und Janni, Wolfgang
(2020):
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 111
Michel, Laura L.; Hartkopf, Andreas D.; Fasching, Peter A.; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haberle, Lothar; Ettl, Johannes; Luftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Volz, Bernhard; Huebner, Hanna; Wimberger, Pauline; Hielscher, Carsten; Mundhenke, Christoph; Kurbacher, Christian; Würstlein, Rachel; Untch, Michael; Overkamp, Friedrich; Huober, Jens; Janni, Wolfgang; Taran, Florin-Andrei; Lux, Michael P.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas und Fehm, Tanja N.
(2020):
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
In: Cancers, Bd. 12, Nr. 10, 3021